Milgamma or Milgamma Compositum, which is more effective

Many believe that these drugs are almost analogues of each other. However, these are different means, despite their similarity.

The cardinal differences are:

Release form:

  • “Milgamma” – in the form of a solution for injection.
  • Milgamma Composite – for oral use.

The number of active components:

  • Milgamma contains elements B1, B6, B12 and lidocaine.
  • Milgamma Composite – benfotiamine (an analogue of vitamin B1) and vitamin B6.

Milgamma Compositum usually causes less adverse reactions, since it does not contain vitamin B12. However, it is for this reason that it is less effective for painful sensations. At the same time, Milgamma Composite is more convenient to use – you just need to drink the tablets with water, and it is impossible to carry out the Milgamma treatment on your own – not every person can inject himself into the muscle.

Preparations can not be used for the same stage of the disease.

“Milgamma” is prescribed by doctors if the disease is in the acute phase: with severe pain caused by osteochondrosis or neuralgia. The drug stops pain, translating it into a passive form.

Milgamma Composite can be taken in situations where the disease is easier, without severe pain and a feeling of stiffness in the patient, as well as in the second stage of treatment, after the end of the course of injections of Milgamma.

Milgamma and Milgamma Composite are vitamin complexes containing B vitamins. Their main task is a beneficial effect on the functioning of the nervous system and the motor apparatus. Also, drugs improve the metabolism of substances, synthesize ATP, etc. However, why are Milgamma prescribed for some patients and Milgamma Composite for others? What is the difference between drugs and which one is most effective?


The drug is a clear red solution for intramuscular administration. It has an analgesic, metabolic and neuroprotective effect.


Vitamins of group B, which are part of the product, have a beneficial effect on diseases of the nerves and motor apparatus of a person.

  • B1 is necessary for carbohydrate metabolism, and is also required in the Krebs cycle and for the formation of ATP and thiamine pyrophosphate.
  • B6 takes part in protein metabolism, and to a lesser extent in the metabolism of fats and carbohydrates.

These substances have a beneficial effect on each other, increasing efficiency in the body. This affects the improvement of the neuromuscular and nervous systems.

  • B12 takes part in the formation of nerve membranes – myelin, and also reduces the strength of pain in case of damage to the nervous system, activates nucleic acid metabolism by stimulating the work of folic acid. Perhaps a decrease in pain that occurs due to damage to the peripheral nerves.
  • Lidocaine in the composition of the solution is an anesthetic that can reduce locally painful sensations.

Milgamma is prescribed in the complex treatment of a number of diseases:

  • Neurological manifestations of osteochondrosis.
  • Night muscle cramps (more common in older people).
  • Polyneuropathies (caused by alcohol or diabetes).
  • Neuropathy.
  • Plexopathy.
  • Ganglionites (including depriving).
  • Retrobulbar neuritis.
  • Paresis of the facial nerve.
  • Neuritis
  • Neuralgia of various origins.

You can not use the tool in the following cases:

  1. For allergies.
  2. With decompensated heart failure.
  3. During pregnancy and lactation.
  4. In childhood.

In case of an overdose, the injection is canceled. The solution is stored only in a dark, cold place (no more than 8 degrees Celsius). However, freezing the solution is prohibited.

Milgamma Composite

The product is available in the form of round, white bulges convex on both sides. The drug is taken orally. Its action is aimed at improving metabolism, making up for deficiency B6, making up for deficiency B1.

Milgamma Composite

The medicine contains benfotiamine, a derivative of thiamine. The element takes part in the metabolism, including the oxidation of glucose. Element B6 in the composition of tablets is necessary for the exchange of amino acids.

They drink these pills for neurological diseases with a confirmed lack of vitamins B1 and B6.

The drug is prohibited for use with:

  • Allergies to the components of the drug.
  • Decompensated heart failure.
  • Congenital intolerance to fructose, glucose malabsorption syndromes, galactose, or with glucose-isomaltose deficiency.
  • During pregnancy and lactation.
  • In childhood, due to the lack of data on the effect of the drug on the children’s body.

The drug is taken orally with a large amount of water.

What do drugs have in common?

Both drugs are necessary for the treatment of various manifestations of osteochondrosis and a number of neurological diseases:

  • Neuritis
  • Ganglionites.
  • Plexopathy.
  • Night cramps.
  • Paresis of the facial nerve.
  • Neuropathy, polyneuropathy.

Both remedies are similar in contraindications. They can not be used when:

  1. Decompensated heart failure.
  2. Allergies to the remedy.
  3. During pregnancy, lactation.
  4. Children’s age.

Both drugs similarly manifest themselves in combination with other drugs:

  • Reception of “Fluorofuratsil” together with one of the drugs leads to inhibition of vitamin B1, since thiamine cannot function with reducing and oxidizing substances.
  • Vitamin B6 is destroyed when combined with ethanol or estrogen-containing drugs.
  • Vitamin B12 cannot actively affect the body when used with antioxidants, vitamins B2 and PP, salts of heavy metals.
  • Milgamma and Milgamma Composite worsen the effect of Levopoda.

The side effects of the two remedies are similar:

  1. Allergy.
  2. Irritation and pain at the site of intramuscular injection.
  3. Cramps.
  4. Headache.
  5. Nausea.
  6. Heart rhythm disturbances.
  7. Confusion.
  8. Dizziness.
  9. Neuropathy with prolonged (more than 6 months) admission.

The composition of the funds is also similar – both drugs contain vitamins B1 and B6.

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *